Pharmacological and therapeutic directions in ADHD: Specificity in the PFC
Open Access
- 1 January 2008
- journal article
- Published by Springer Science and Business Media LLC in Behavioral and Brain Functions
- Vol. 4 (1), 12
- https://doi.org/10.1186/1744-9081-4-12
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Divergent Plasticity of Prefrontal Cortex NetworksNeuropsychopharmacology, 2007
- Alpha-2 Adrenergic Receptor Agonists for the Treatment of Attention-Deficit/Hyperactivity Disorder: Emerging Concepts from New DataJournal of Child and Adolescent Psychopharmacology, 2007
- Dopamine D1 receptor activation regulates sodium channel‐dependent EPSP amplification in rat prefrontal cortex pyramidal neuronsThe Journal of Physiology, 2007
- What do Dopamine Transporter and Catechol-O-Methyltransferase Tell us About Attention Deficit–Hyperactivity Disorder? Pharmacogenomic ImplicationsAustralian & New Zealand Journal of Psychiatry, 2007
- D1 receptors in prefrontal cells and circuitsBrain Research Reviews, 2000
- The lateral hypothalamic area revisited: Ingestive behaviorNeuroscience & Biobehavioral Reviews, 1996
- Cloning, expression and structure of catechol-O-methyltransferaseBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995
- Delayed-response deficit induced by local injection of the α2-adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeysBehavioral and Neural Biology, 1994
- Reserpine impairs spatial working memory performance in monkeys: reversal by the α2-adrenergic agonist clonidineBrain Research, 1993
- Analysis of the effects of frontal lesions in monkeys: I. Variations of delayed alternations.Journal of Comparative and Physiological Psychology, 1955